Archives of Medical Research
Volume 41, Issue 2 , Pages 67-74 , February 2010

MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251

  • Shihai Luan

      Affiliations

    • Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, China
    • ,
  • Linlin Sun

      Affiliations

    • Department of Radiology, Huashan Hospital of Fudan University, Shanghai, China
    • ,
  • Fengping Huang

      Affiliations

    • Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, China
    • Corresponding Author InformationAddress reprint requests to: Fengping Huang, Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai Neurosurgical Center, The 3rd Ward, 12 Middle Wulumuqi Road, Shanghai 200040, China; Phone: +86 21 52889999; FAX: +86 21 50301919.

Received 14 August 2009 ,Accepted 11 November 2009.

References 

  1. Surawicz TS, Davis F, Freels S, et al. Brain tumor survival: results from the National Cancer Center Data Base. J Neurooncol. 1998;40:151–160
  2. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature. 2004;432:307–315
  3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310
  4. Hermeking H. p53 enters the microRNA world. Cancer Cell. 2007;12:414–418
  5. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008;9:102–114
  6. Hatfield S, Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res. 2008;331:57–66
  7. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007;6:2127–2132
  8. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60
  9. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130–1134
  10. He L, He XY, Scott W, et al. microRNAs join the p53 network—another piece in the tumour suppression puzzle. Nat Rev. 2007;7:819–822
  11. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007;26:5017–5022
  12. Sun F, Fu H, Liu Q, et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008;582:1564–1568
  13. Fujita Y, Kojima K, Hamada N, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun. 2008;377:114–119
  14. Ji Q, Hao XB, Meng Y, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008;8:266–302
  15. Yamakuchi M, Ferlito M, Lowenstein CJ, et al. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008;36:13421–13426
  16. Li N, Fu H, Tie Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009;275:44–53
  17. Yan D, Zhou X, Chen X, et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci. 2009;50:1559–1565
  18. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene. 2007;26:5489–5504
  19. Kuzmichev A, Margueron R, Vaquero A, et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA. 2005;102:1859–1864
  20. Huffman DM, Grizzle WE, Bamman MM, et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007;67:6612–6618
  21. Hida Y, Kubo Y, Murao K, et al. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res. 2007;299:103–106
  22. Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23:2369–2380
  23. Cheng HL, Mostoslavsky R, Saito S, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA. 2003;100:10794–10799
  24. Khokon KD, Zhong Y, Liu YT, et al. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007;98:1845–1852
  25. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007;26:731–743
  26. Dijkstra1 MK, van Lom K, Tielemans D, et al. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation. Leukemia. 2009;23:625–627
  27. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26:745–752
  28. Wei JS, Song YK, Durinck S, et al. The MYCN oncogene is a direct target of miR-34a. Oncogene. 2008;27:5204–5213
  29. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838
  30. Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334:1351–1358
  31. Kang CS, Pu PY, Jia ZF, et al. Preliminary study on the miRNA expression profiles in several glioma cell lines. Chin J Neurosurg. 2008;24:468–470
  32. Shono T, Tofilon PJ, Schaefer TS, et al. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res. 2002;62:1069–1076

PII: S0188-4409(10)00021-4

doi: 10.1016/j.arcmed.2010.02.007

Archives of Medical Research
Volume 41, Issue 2 , Pages 67-74 , February 2010

Article Tools

* Image Usage & Resolution